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Abstract
Background: Previous research using the National Health and Nutrition Examination Surveys (NHANES) data 
documented a significant downward trend in secondhand smoke (SHS) exposure between 1988 and 2002. The 
objective of this study was to assess whether the downward trend in exposure continued from 2001 through 2006.
Methods: We analyzed data from the 2001-2006 NHANES to estimate exposure of nonsmokers to SHS. Geometric 
means of serum cotinine levels for all nonsmokers were computed.
Results: Overall serum cotinine levels (95% Confidence Intervals) in 2001-2002, 2003-2004, and 2005-2006 were 0.06 
ng/mL (0.05-0.07), 0.07 ng/mL (0.06-0.09), and 0.05 ng/mL (0.05-0.06), respectively. Subgroup analysis by age, gender, 
and race/ethnicity groups showed similar trends in cotinine levels. Children, males, and non-Hispanic Blacks had higher 
cotinine levels than adults, females, and non-Hispanic Whites and Mexican Americans, respectively. Insignificant P 
values from the Wald test indicate that serum cotinine levels did not differ over time.
Conclusions: The long-term trend of declining exposure to SHS among nonsmokers appears to have leveled off. 
However, disparities noted in previous research persist today, with the young, non-Hispanic Blacks, and males 
experiencing higher levels of exposure.
Background
Secondhand smoke (SHS) is a significant health hazard
among nonsmokers in the United States. The National
Toxicology Program has estimated that at least 250 chem-
icals in SHS are known to be toxic or carcinogenic. When
nonsmokers are exposed to SHS, they are inhaling the
same cancer-causing agents that current smokers inhale.
Scientific evidence has documented SHS as a cause of
major disease and death in the United States [1]. Second-
hand smoke has been linked to 35,000 deaths from heart
disease and 3000 deaths from lung cancer [2].
The health effects of SHS are particularly concerning in
children. A large body of literature has linked SHS expo-
sure to various respiratory illnesses and developmental
problems in this group. Strong evidence has shown that
children exposed to SHS are at higher risk for middle ear
disease, asthma, respiratory symptoms, lung growth, and
pulmonary function [1]. On an annual basis, more than
200,000 episodes of childhood asthma have been directly
attributable to parental smoking [3]. In children, SHS
exposure has also been associated with adverse behav-
ioral outcomes, cognitive impairment, and poor school
performance [1,4].
Secondhand smoke is defined as a mixture of smoke
released by the burning end of a cigarette ("sidestream
smoke") combined with cigarette smoke exhaled by the
smoker ("mainstream smoke") [1]. Secondhand smoke is
also referred to as environmental tobacco smoke. Since
1986, when the Surgeon General published a report
establishing a causal link between SHS and major dis-
eases, the body of supportive scientific literature has
grown. In response to the growing body of scientific liter-
ature linking SHS with serious diseases, local and state
governments across the nation have introduced a signifi-
cant number of public health initiatives to reduce tobacco
exposure, such as restricting smoking in work places and
public settings (i.e., restaurants, bars, casinos, vehicles).
These smoke-free legislative policies have proven to be
effective for raising the public's awareness about the dan-
gers of smoking and protecting the health of nonsmokers
[1]. As an example, New York implemented a state law in
2003, requiring all indoor workplaces and public places to
be smoke-free. One year following its implementation,
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self-reported SHS exposure at work decreased by 98%
among nonsmoking employees of restaurants, bars, and
bowling facilities, and their saliva cotinine levels
decreased by 78% [5].
On a national level, SHS exposure among US nonsmok-
ers has declined substantially since the late 1980 s [1,6].
Using the National Health and Nutrition Examination
Surveys (NHANES), Pirkle et al [6] described SHS expo-
sure over a period of 14 years between 1988 and 2002.
The authors documented a substantial decline of approx-
imately 70% in serum cotinine concentrations of non-
smokers during this period, although nonsmoking
children, males, and non-Hispanic Blacks were found to
have significantly higher serum cotinine concentrations
than adults, females and non-Hispanic Whites and Mexi-
can Americans, respectively.
Public health initiatives have had an important impact
on the progress of tobacco control. Additionally, the
decrease in the prevalence of cigarette smoking, from
28% in 1988 to 20.8% in 2006, has helped to accelerate the
reduction of tobacco exposure [7].
The current manuscript builds on the earlier 1988-2002
findings from Pirkle et al. [6]. The study objectives were
2-fold: (1) to assess whether the downward trend in SHS
exposure level has continued since 2002 and (2) to repli-
cate, update, and expand upon the work of Pirkle et al.
work of examining the cotinine levels of nonsmokers by
using the most recently available NHANES data from
2001-2006.
Methods
Data source
Data were obtained from the NHANES conducted from
2001 to 2006. The NHANES was conducted by the
National Center for Health Statistics of the Centers for
Disease Control and Prevention (Atlanta, Georgia) and
approved by the Institutional Review Board of the
National Center for Health Statistics. The NHANES used
a stratified, multistage, clustered probability design to
select a nationally representative sample of the civilian,
non-institutionalized US population. This study analyzed
data over 3 time periods: 2001-2002, 2003-2004, and
2005-2006. Further details regarding the NHANES may
be found elsewhere [8].
Population selection
For comparison of NHANES data across time, we
adopted methodology from previous publications by
Pirkle et al to define non-smokers as individuals with a
serum cotinine concentration ≤10 ng/mL. The study pop-
ulation included individuals aged 4 years and older at the
time of their participation in the NHANES and who
reported being non-Hispanic White, non-Hispanic Black,
or Mexican American. A total of 19,890 participants were
included in this study. The limit of detection in cotinine
analysis was defined as individuals with a serum cotinine
concentration at 0.05 ng/mL.
All survey participants (or their parent or guardian)
provided written informed consent, answered health and
nutrition questionnaires at home, and completed a com-
prehensive set of physical examinations in a mobile
examination center. The serum cotinine analysis was per-
f o r m e d  o n  a  b l o o d  s a m p l e  d r a w n  d u r i n g  t h e  p h y s i c a l
examination.
Statistical analysis
SUDAAN statistical software (Research Triangle Insti-
tute, Research Triangle Park, North Carolina) was used to
generate the variance estimates to account for the com-
plex survey design. Data were analyzed using sampling
weights to generate population estimates and adjust for
the unequal probabilities of selection. The proportion of
sample with a limit of detection of 0.050 ng/mL across
the study time periods was generated. Given serum coti-
nine values have been shown to follow a log-normal dis-
tribution, [6] regression models for each survey year were
performed using the log of serum cotinine as the depen-
dent variable. The independent variables analyzed
included: age (4-11, 12-19, 20+ years), gender, and race/
ethnicity (non-Hispanic White, non-Hispanic Black, or
Mexican American). Adults are defined as individuals 20
years old and above. Geometric means and 95% confi-
dence intervals (CI) of serum cotinine were generated for
all main level and 2-way interaction effects. The Wald test
was used to test for a change over time overall and within
each subgroup.
Results
Demographic characteristics
This analysis was limited to nonsmokers, defined as those
with a serum cotinine concentration ≤10 ng/mL. Of the
31,509 participants in the 2001-2006 NHANES surveys,
27,143 had a serum cotinine concentration ≤10 ng/mL.
Further exclusions based on age (below age of 4 years)
and race/ethnicity ("Other") limited the final study sam-
ple to 19,890 participants (6942 in 2001-2002, 6377 in
2003-2004, and 6571 in 2005-2006). On average, 187 mil-
lion children and adults in the United States were repre-
sented within each study period. The sample
characteristics did not vary by study time period. After
adjusting for the complex survey design in each of the 3
study time periods, on average, 72% of the nonsmokers
were adults, 46% were male, and 76% were non-Hispanic
White.
Serum cotinine levels
The geometric means of serum cotinine levels of United
States nonsmokers, overall and by subgroups (age, gen-Chen et al. BMC Public Health 2010, 10:359
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der, and race/ethnicity) are presented in Table 1. The 3
time periods included in this table and subsequent figures
are 2001-2002, 2003-2004, and 2005-2006. The geometric
means of serum cotinine in overall nonsmokers were 0.06
ng/ml, 0.07 ng/ml, and 0.05 ng/ml, during 2001-2002,
2003-2004, and 2005-2006, respectively. Although the
cotinine levels in 2005-2006 were either the same or
lower than in 2001-2002, the insignificant P values, over-
all and within each subgroup, suggest that serum cotinine
levels did not differ over time. Figure 1 shows the overall
cotinine levels in longitudinal context from 1988 through
2006 by embedding previous data with our current find-
ings [6]. The pattern of results within the age, gender, and
race/ethnicity groups remained similar across the 3 time
periods. Children, males, and non-Hispanic Blacks had
higher cotinine levels than adults, females, and non-His-
Table 1: Serum cotinine geometric means (95% confidence interval) for nonsmokers in United States populations 2001-
2006
Geometric means of serum cotinine (ng/mL) NHANES
2001-2002
NHANES
2003-2004
NHANES
2005-2006
P value
Overall 0.06
(0.05, 0.07)
0.07
(0.06, 0.09)
0.05
(0.05, 0.06)
0.12
Overall - Undetected 0.018
(0.016, 0.020)
0.018
(0.017, 0.020)
0.019
(0.018, 0.020)
0.75
Age: (years)
4-11 0.11
(0.07, 0.15)
0.14
(0.07, 0.20)
0.08
(0.06, 0.10)
0.05
4-11 - Undetected 0.018
(0.015, 0.020)
0.018
(0.017, 0.020)
0.018
(0.018, 0.020)
0.84
12-19 0.09
(0.05, 0.12)
0.11
(0.08, 0.14)
0.08
(0.06, 0.10)
0.08
12-19 - Undetected 0.018
(0.016, 0.020)
0.018
(0.017, 0.020)
0.19
(0.018, 0.021)
0.59
20+ 0.05
(0.04, 0.06)
0.06
(0.04, 0.07)
0.05
(0.04, 0.05)
0.29
20+ - Undetected 0.018
(0.016, 0.020)
0.018
(0.017, 0.020)
0.19
(0.018, 0.020)
0.79
Gender
Male 0.07
(0.05, 0.09)
0.09
(0.07, 0.10)
0.07
(0.06, 0.07)
0.08
Male - Undetected 0.019
(0.016, 0.021)
0.020
(0.019, 0.021)
0.020
(0.019, 0.021)
0.51
Female 0.05
(0.04, 0.06)
0.06
(0.05, 0.07)
0.05
(0.04, 0.06)
0.22
Female - Undetected 0.018
(0.016, 0.019)
0.017
(0.016, 0.019)
0.018
(0.017, 0.019)
0.88
Race/ethnicity:
Non-Hispanic White 0.05
(0.04, 0.06)
0.07
(0.05, 0.08)
0.05
(0.04, 0.06)
0.14
Non-Hispanic White - Undetected 0.018
(0.016, 0.020)
0.018
(0.017, 0.019)
0.19
(0.018, 0.020)
0.66
Non-Hispanic Black 0.16
(0.13, 0.19)
0.14
(0.10, 0.19)
0.11
(0.09, 0.15)
0.11
Non-Hispanic Black - Undetected 0.23
(0.020, 0.030)
0.22
(0.020, 0.024)
0.22
(0.021, 0.024)
0.88
Mexican American 0.06
(0.04, 0.08)
0.05
(0.04, 0.07)
0.05
(0.04, 0.06)
0.40
Mexican American - Undetected 0.18
(0.017, 0.020)
0.18
(0.016, 0.020)
0.17
0.016, 0.019)
0.55Chen et al. BMC Public Health 2010, 10:359
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panic White and Mexican Americans, respectively. The
proportion of individuals with undetectable cotinine lev-
els were 40%, 41%, and 45%, during 2001-2002, 2003-
2004, and 2005-2006, respectively.
The adjusted geometric means and 95% CIs for 2-way
interaction over the 3 time periods are presented in Fig-
ure 2, Figure 3, Figure 4. The results of a 2-way interac-
tion between age and gender are presented in Figure 2.
The noted age effect, children appearing to have higher
cotinine levels than adults, is observed in both males and
females. During 2003-2004, cotinine levels showed a
notable increase across all 3 age groups since 2001-2002,
but these increases seem to have disappeared by 2005-
2006. The noted gender effect, males appearing to have
higher cotinine levels than females, is observed across all
age groups over time, except in children aged 4-11 years
old during 2001-2002 and 2005-2006.
The results of a 2-way interaction between race/ethnic-
ity and gender are presented in Figure 3. The noted race/
ethnicity effect, non-Hispanic Blacks showing higher
cotinine levels than non-Hispanic Whites and Mexican
Americans, was consistent across gender groups over
time. Males also consistently showed higher cotinine lev-
els than females across the race/ethnicity groups. During
all 3 time periods examined, both male and female non-
Hispanic Blacks displayed notably higher cotinine levels
than their respective comparison groups.
The results of a 2-way interaction between age and
race/ethnicity are presented in Figure 4. The noted age
Figure 2 Geometric means and 95% confidence intervals for non-
smokers in the United States by age and gender, 2001-2002, 
2003-2004, and 2005-2006.
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Figure 3 Geometric means and 95% confidence intervals for non-
smokers in the United States by race/ethnicity and gender, 2001-
2002, 2003-2004, and 2005-2006. *Non-Hispanics.
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Figure 4 Geometric means and 95% confidence intervals for non-
smokers in the United States by race/ethnicity, 2001-2002, 2003-
2004, and 2005-2006. *Non-Hispanics.
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Figure 1 Geometric means and 95% confidence intervals for non-
smokers in the United States from 1988 through 2006. *Exposure 
data for 1998 through 2000 are derived from Pirkle et al [6] and embed-
ded for comparison to current study findings.
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effect of children at higher risk of SHS exposure is dis-
tinctly visible among non-Hispanic Whites and non-His-
panic Blacks. This age effect is not visible among Mexican
Americans across all 3 time periods and becomes less vis-
ible among non-Hispanic Whites by 2005-2006.
Discussion
This study reports updated findings using the latest avail-
able NHANES data between 2001 and 2006. Overall, our
results suggest that the long-term trend of declining
exposure to SHS among nonsmokers, as reported by
Pirkle et al. [6], have stabilized since 2002. While the
work of Pirkle et al. provided evidence to show the prog-
ress and impact of antismoking policies and public health
efforts over the last decade, our current findings reveal
that declines in SHS exposure seem to have leveled off.
Despite the stabilizing downward trend in national
exposure, the demographic and racial/ethnic differences
noted by Pirkle et al. [6] persist today, with the young
(children and adolescents age 4-19 years), males, and
non-Hispanic Blacks experiencing higher levels of SHS
exposure. While male nonsmokers were consistently
exposed to higher cotinine levels than female nonsmok-
ers, their overall cotinine levels remained consistently
below 0.1 ng/mL over time. Children and adolescents age
4-19 years of non-Hispanic Black descent had consis-
tently higher cotinine levels than their comparison
groups across the 3 time periods examined. During 2005
to 2006, overall cotinine levels in children age 4-11 years
fell below 0.1 ng/mL. While there is no direct evidence
from this study to address the possibility of a declining
trend in children's exposure, this finding is consistent
with the Healthy People 2010 objective calling for no
more than 45% of nonsmokers to have cotinine levels
>0.1 ng/mL [6].
In children, our findings are consistent with previous
Centers for Disease Control and Prevention publications
concluding that children are more heavily exposed to
SHS than nonsmoking adults. Specifically, children's
measured cotinine levels have been twice that of adults
[9]. The reasons for this are multifactorial. Children have
a ventilation rate that is higher, proportional to their body
size, than that seen in adults. The toxicity level in SHS is
in effect amplified in children as they inhale many of the
same cancer-causing substances as current smokers [10].
In addition, children get most of their smoke exposure in
private homes and vehicles [11]. Children can not choose
who they live with, whereas nonsmoking adults can
choose to live with nonsmokers or have people smoke
outside the home. There is currently little data to inform
on the specific impact of controlling private household or
vehicle exposure.
Concerning racial and ethnic differences in exposure,
our findings are consistent with previous studies con-
cluding that Black nonsmokers have higher serum coti-
nine levels than do White or Mexican American
nonsmokers [6]. It is also consistent with previous studies
that documented differences between Black and White
smokers [12,13].
One question that these data raise is whether ethnic/
demographic differences in African Americans, males,
and children are due to their differences in nicotine
metabolism. In 1998, Pérez-Stable et al. [12] reported that
African Americans take in more nicotine per cigarette
than whites, which may explain why African Americans
have a higher incidence of lung cancer. In general, African
Americans have a slower rate of nicotine metabolism
than Caucasians, resulting in greater accumulation of
cotinine.
The results from the 2-way interaction between age and
gender are notable, showing the highest exposure levels
in children and adolescents age 4-19 years of non-His-
panic Black descent as compared with other comparison
groups over time. This finding is consistent with previous
studies linking a lower socioeconomic status to a greater
probability of SHS exposure in children. Previous
research has suggested that persons with low income are
more likely to be exposed in the home than are other
income groups. Specifically, 58% of children in house-
holds with annual incomes under $10,000 per year expe-
rience SHS exposure, as compared with 30% of children
in households with annual incomes greater than $40,000
[14]. It has been previously documented that African
Americans earn less money per year and have the highest
poverty rates as compared with other race/ethnicity
groups [15].
Our study has some strengths and limitations that
should be noted. The data used in this analysis comes
from a large national sample of individuals who are repre-
sentative of the United States civilian non-institutional-
ized population. To validate the differences and/or
similarities that are observed over time, consistent meth-
odology was utilized across all time periods examined.
One important caveat to consider in understanding the
current study findings is the tool being used to character-
ize exposures over time. While cotinine represents the
most widely used biomarker (primarily due to its specific-
ity, half-life, and ease of measurement), questionnaire
reports remain the primary tool to track exposures over a
certain time period. Previous findings from questionnaire
reports have been compared with biomarker data and
have demonstrated high degrees of correlation between
the two ways of exposure assessment [16]. In addition,
this study is currently missing an in-depth analysis of
chronic conditions (e.g., asthma attacks and lung cancer)
given infrequent observations within a single wave of
data. Such information would better inform and substan-Chen et al. BMC Public Health 2010, 10:359
http://www.biomedcentral.com/1471-2458/10/359
Page 6 of 7
tiate our understanding of the relationship between
serum cotinine levels and impact on various health risks.
Important GAPS and research questions remain con-
cerning the progress and impact of reducing SHS expo-
sure. Despite the relatively widespread implementation of
smoke-free laws in the US, there are opportunities for
states to implement greater protection. We now know
that only 100% smoke-free indoor air laws can effectively
protect the public from secondhand smoke. Yet, as of the
end of 2008, only 16 states have provided 100% smoke-
free indoor air laws for bars, restaurants, government
worksites, and private worksites [17]. The extent of
smoke-free legislation was likely even less comprehensive
two years prior, during which the data for the current
analysis was captured (2001 - 2006). It is possible that an
analysis using post-2006 data may demonstrate improve-
ments though these data were not available at the time of
the current study. In addition, indoor spaces such as
homes and vehicles represent another critical area of
focus with regard to reducing a major location of expo-
sure.
Finally, it is possible that the measurement of second-
hand smoke exposure using serum cotinine analysis is
approaching its limits of detection and possibly introduc-
ing challenges to demonstrate further declines in expo-
sure. Further efforts of continuous method
improvements could lead to more sensitive instruments
that will serve to be even more effective in monitoring
and detecting further exposure declines.
Conclusions
Our findings reflect long-term declining trends in SHS
exposure among nonsmokers to be stabilizing. These
findings could reflect opportunities for implementing
greater protection. Since there are no risk-free levels of
SHS [1], previous studies have established that the most
effective approach to protect nonsmokers is to imple-
ment smoke-free policies that completely eliminate expo-
sure. While some states and locales are implementing
smoke-free policies and legislation, the parameters are
generally not uniform and vary widely by geographical
region, occupation, and industry[18]. It would also be
important to target efforts on subgroups that are persis-
tently at-risk for high SHS exposure, namely the young,
males, and non-Hispanic Blacks. Finally, it will be neces-
sary to introduce more sensitive instruments capable of
detecting incremental declines in SHS exposure.
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